CVRX INC (CVRX)

US1266381052 - Common Stock

11.78  +0.07 (+0.6%)

After market: 11.78 0 (0%)

News Image
8 days ago - CVRx, Inc.

CVRx Announces Appointment of Robert Allen John as Chief Revenue Officer

MINNEAPOLIS, June 25, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (

News Image
25 days ago - Pomerantz LLP

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of CVRx, Inc. - CVRX

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of CVRx, Inc. ("CVRx" or the "Company") (NASDAQ: CVRX). Such investors are advised...

News Image
a month ago - Pomerantz LLP

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of CVRx, Inc. - CVRX

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of CVRx, Inc. ("CVRx" or the "Company") (NASDAQ: CVRX). Such investors are advised...

News Image
a month ago - Pomerantz LLP

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of CVRx, Inc. - CVRX

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of CVRx, Inc. ("CVRx" or the "Company") (NASDAQ: CVRX). Such investors are advised...

News Image
a month ago - CVRx, Inc.

CVRx to Present at the William Blair 44th Annual Growth Stock Conference

MINNEAPOLIS, May 22, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (

News Image
2 months ago - Pomerantz LLP

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of CVRx, Inc. - CVRX

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of CVRx, Inc. ("CVRx" or the "Company") (NASDAQ: CVRX). Such investors are advised...

News Image
2 months ago - CVRx, Inc.

CVRx Announces Key Senior Leadership Team Hires

Dr. Philip B. Adamson will join as Chief Medical OfficerBonnie Handke will join as Senior Vice President of Patient Access, Reimbursement, and Healthcare...

News Image
2 months ago - Pomerantz LLP

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of CVRx, Inc. - CVRX

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of CVRx, Inc. ("CVRx" or the "Company") (NASDAQ: CVRX). Such investors are advised...

News Image
2 months ago - Market News Video

CVRx is Now Oversold (CVRX)

News Image
2 months ago - InvestorPlace

Why Is Cemtrex (CETX) Stock Down 40% Today?

Cemtrex stock is falling on Wednesday after launching a public offering for CETX shares and signing a standstill agreement with a note holder.

News Image
2 months ago - InvestorPlace

Why Is CVRx (CVRX) Stock Down 32% Today?

CVRx stock is falling hard on Wednesday after the company posted EPS and revenue misses in its earnings report for Q1 2024.

News Image
2 months ago - InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

It's time to dive into the biggest pre-market stock movers as we check out all of the hottest news for Wednesday morning!

News Image
2 months ago - BusinessInsider

CVRX Stock Earnings: CVRx Misses EPS, Misses Revenue for Q1 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips CVRx (NASDAQ:CVRX) just reported results for the first quarter of 2024.CVRx rep...

News Image
2 months ago - InvestorPlace

CVRX Stock Earnings: CVRx Misses EPS, Misses Revenue for Q1 2024

CVRX stock results show that CVRx missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.

News Image
2 months ago - CVRx, Inc.

CVRx Reports First Quarter 2024 Financial and Operating Results

MINNEAPOLIS, April 30, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing,...

News Image
3 months ago - CVRx, Inc.

CVRx to Report First Quarter 2024 Financial and Operating Results and Host Conference Call on April 30th, 2024

MINNEAPOLIS, April 16, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing,...

News Image
3 months ago - CVRx, Inc.

CVRx announces availability of additional data supporting long-term benefits of Barostim

BeAT-HF trial data published in the European Journal of Heart Failure and new abstracts presented at THT conference MINNEAPOLIS, Minn., April 15, 2024 ...

News Image
3 months ago - Market News Video

CVRx is Now Oversold (CVRX)

News Image
3 months ago - Market News Video

CVRx Shares Cross Below 200 DMA

News Image
4 months ago - Market News Video

Notable Monday Option Activity: CVRX, PSA, ARQT

News Image
4 months ago - Market News Video

CVRx Enters Oversold Territory (CVRX)

News Image
5 months ago - Market News Video

RSI Alert: CVRx (CVRX) Now Oversold

News Image
5 months ago - CVRx, Inc.

CVRx Announces Appointment of Kevin Hykes as President and Chief Executive Officer

Appointment effective February 12 following Nadim Yared’s retirement Hykes currently serves as Augmedics’ President and CEO, and has served on CVRx’s Board...